AUSTRALIANS will be eligible for a 'superjab' to protect them from both COVID and the flu by 2026 thanks to Moderna, The Weekend Australian has reported.
The US biotech company has slated its anticipated launch date for the product, which will combine vaccines for the flu and COVID-19 into a single shot for the first time.
The northern hemisphere will be able to access the jab from late 2025 for its flu season, subject to regulatory approval, with a launch in Australia to follow in 2026.
Australia will also play a key role in manufacturing the 'superjab', as Moderna is building a new factory in Melbourne, which is expected to begin operation by 2025.
The facility is part of a 10-year partnership with the gov't to produce mRNA vaccines locally, reported the publication.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Sep 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Sep 23
